Forbion Capital Partners


Venture Capital


Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing drugs and technologies, with a clear focus on product development. The Forbion team is specialized in the evaluation of late stage preclinical / early stage clinical development programs. Forbion also invests in medical device companies with a focus on interventional cardiology and gastroenterology. The Forbion team began operating in 2000 as ABN AMRO Capital Life Sciences, the venture arm of ABN AMRO Bank NV. In December 2006 the group broadened its investor base, became independent, and changed its name to Forbion Capital Partners. Forbion currently has EUR 200 million under management.


🇳🇱 Netherlands



🧬 Biotechnology

🏥 Health Care



Series A

Series B

Series C

Series D

Series E


Sector Restriction

Contact information:

Support this MVP!

Get immediate full data access & updates on this project by signing up!

I've been building this app in my sparetime. That includes, well, everything.

I don't want your money. I want your engagement.

I want to extend this app with more features including:

  • More advanced filtering and sorting
  • Export to various formats like Excel or just CSV
  • More data, e.g. contact information to key people (already have the data actually), ticket sizes etc.

..but only if anyone is interested 😅

Your full name

Your email

Full LinkedIn or Twitter/X URL. Copy & paste that thing

Paste your favourite emoji here. Only one. No cheating.

Get inspiration here:
Made with 🎃 by Alex